Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,183.2
3.8 (0.12%)

 

  • STI Straits Times Index
    3,183.2
    3.8 (0.12%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,604.0
    5.7 (0.36%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,743.5
    -157.3 (-0.54%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,391.1
    -25.6 (-0.75%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,713.2
    92.2 (0.31%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,050.3
    -
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 299.9M
  • Value: 216.4M
  • Rise: 106
  • Fall: 83
  • Unch: 581

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.199+0.002
P5 Capital0.039+0.001
Jiutian Chemical0.099-0.002
Rex Intl0.182-0.001
Oceanus^0.041-0.001
Anchor Resources0.031-
Genting Sing0.900-0.005
MM2 Asia0.058-0.001
Ntegrator Intl0.015+0.001
GHY Culture0.745-0.010

World Indices

World Indices
Name Last Change
Nasdaq 13,857.8 -138.3
HSI 28,721.2 -179.6
HSCEI 10,888.3 -111.0
Jakarta 6,056.0 +5.7
Nikkei 225 29,718.5 +97.6
SSE Comp 3,385.7 -31.1
Shanghai A 3,548.6 -32.6
Shanghai B 245.6 -0.3
KOSPI 3,192.4 +10.0

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

SQZ BIOTECHNOLOGIES CO SQZ BIOTECHNOLOGIES CO
Updated on 14 Apr 2021 (End of trading day)
Last (USD): 13.060 Change: +0.030 High: 13.350 Remarks: -
Change (%): +0.23 Low: 12.620
Open 12.910 Yesterday's Close 13.030000000000001
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 139,469 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.81275 Trailing EPS (USD) e -1.81275 NAV (USD) b 4.5640
PE a - Trailing PE f - Price / NAV b 2.8615
Dividend (USD) d - Cash In Hand (USD) g 6.1126 Issued & Paid-up Shares c 27,869,800
Dividend Yield (%) d - Price / Cash In Hand g 2.137 Treasury Shares h -
Market Cap (M) 363.980 Enterprise Value (M) 240.718
Piotroski F Score 2 Exchange Code SQZ Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 67.5
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 19 Mar 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 28 Oct 2020.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference SQZ BIOTECHNOLOGIES CO NYSE 363.980 - - 2.8615 -
Industry Biotechnology NYSE 1,765.921 55.281 158.853 5.2718 -
Local Peer EMERGENT BIOSOLUTIONS INC NYSE 3,989.872 13.077 13.077 2.7573 -
Local Peer ARCUS BIOSCIENCES INC NYSE 2,353.799 - - 4.6860 -
Local Peer NUVATION BIO INC NYSE 2,518.211 - - 17.7074 -
Local Peer MYOVANT SCIENCES LTD NYSE 1,589.012 - - -5.8709 -
Local Peer ENZO BIOCHEM INC NYSE 162.048 - - 2.6225 -
Global Peer AMGEN INC NASDAQ 143,731.695 19.787 19.787 15.2760 2.575
Global Peer CSL LTD ASX 121,881.136 38.861 32.025 11.5338 1.096
Global Peer GILEAD SCIENCES INC NASDAQ 82,055.980 667.143 667.122 4.5081 4.157
Global Peer ILLUMINA INC NASDAQ 58,078.413 88.534 88.534 12.3729 -
Global Peer MODERNA INC NASDAQ 64,040.805 - - 25.0023 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 56,197.804 20.725 20.725 6.4693 -
Global Peer WUXI BIO HKEx 440,146.540 231.924 231.926 18.0521 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 51,547.619 14.673 14.673 4.6754 -
Global Peer BIOGEN INC NASDAQ 40,016.013 10.003 10.003 3.7397 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 34,306.822 56.856 56.856 2.9445 -
Other Global Peers BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), BEIGENE (HKEx), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), SEAGEN INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), SINO BIOPHARM (HKEx), INCYTE CORPORATION (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), NOVAVAX INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ZAI LAB-SB (HKEx), NEUROCRINE BIOSCIENCES INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), EXELIXIS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), TG THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), JOINN (HKEx), INTELLIA THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), Lonza (SGX), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), OLINK HLDG AB SPON ADS EACH REP 1 ORD SHS (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), GENSCRIPT BIO (HKEx), AGIOS PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), SEER INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), INSMED INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ALKERMES PLC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), ORGANOGENESIS HOLDINGS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), INSTIL BIO INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), 3SBIO (HKEx), XENCOR INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), FIBROGEN INC (NASDAQ), MACROGENICS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), VIVA BIOTECH (HKEx), LUMINEX CORP(DEL) (NASDAQ), CYTOKINETICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), BIOATLA INC (NASDAQ), JW THERAP-B (HKEx), JACOBIO-B (HKEx), AURINIA PHARMACEUTICALS INC (NASDAQ), KINTOR PHARMA-B (HKEx), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), IMMUNOVANT INC (NASDAQ), UNIQURE N.V. (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), ALLOVIR INC (NASDAQ), POLYNOVO LIMITED (ASX), REGENXBIO INC (NASDAQ), IMMUNOGEN INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), EDGEWISE THERAPEUTICS INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), PRECIGEN INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), MIMEDX GROUP INC (NASDAQ), HAOHAI BIOTEC (HKEx), REPLIMUNE GROUP INC (NASDAQ), ALPHAMAB-B (HKEx), ALECTOR INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), FRONTAGE (HKEx), OCUGEN INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), VOR BIOPHARMA INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), AFFIMED N V (NASDAQ), NKARTA INC (NASDAQ), MESOBLAST LTD (ASX), PLIANT THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), VAXCYTE INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), ASCENTAGE-B (HKEx), RHYTHM PHARMACEUTICALS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), CURIS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), PERSONALIS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), JHBP-B (HKEx), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), CORTEXYME INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), HUMANIGEN INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), TELIX PHARMACEUTIC (ASX), VANDA PHARMACE INC (NASDAQ), MERUS B V (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), INHIBRX INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), IMMATICS N V (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), CHIMERIX INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), ARDELYX INC (NASDAQ), COMPUGEN (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), KADMON HLDGS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ATHIRA PHARMA INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), VAXART INC (NASDAQ), IMUGENE LIMITED (ASX), MEIRAGTX HOLDINGS PLC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), ANAPTYSBIO INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), AGENUS INC (NASDAQ), IKENA ONCOLOGY INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), IVERIC BIO INC (NASDAQ), SINOMAB BIO-B (HKEx), RAPT THERAPEUTICS INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), AKOUOS INC (NASDAQ), XBIOTECH INC (NASDAQ), DPHARMA (Bursa), PRECISION BIOSCIENCES INC (NASDAQ), AVROBIO INC (NASDAQ), ALTIMMUNE INC (NASDAQ), LEE'S PHARM (HKEx), SINOVAC BIOTECH LTD (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), VERASTEM INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), XOMA CORP (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), CHEMOMAB THERAPEUTICS LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), ATRECA INC (NASDAQ), OPTHEA LIMITED (ASX), FLEXION THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), ADICET BIO INC (NASDAQ), ESSEX BIO-TECH (HKEx), ASCLETIS-B (HKEx), SESEN BIO INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), PUMA BIOTECHNOLOGY INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), LAVA THERAPEUTICS NV (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), ANTEOTECH LIMITED (ASX), SPRUCE BIOSCIENCES INC (NASDAQ), ATHERSYS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), BELLUS HEALTH INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), ONCORUS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), IMMUNOME INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), TREVENA INC (NASDAQ), NANOVIRICIDES INC (NYSE American), KAMADA LTD (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), NEXTCURE INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), IMMUTEP LTD (ASX), LARIMAR THERAPEUTICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), NEXT SCIENCE LTD (ASX), MEDICINOVA INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), BIOVIE INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), SAVARA INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), EQUILLIUM INC (NASDAQ), IMV INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), EVOGENE LTD (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), ONCOLYTICS BIOTECH INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), CHIASMA INC (NASDAQ), INMUNE BIO INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), GAIN THERAPEUTICS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), CONTRAFECT CORP (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), BIONOMICS LTD (ASX), CHAMPIONS ONCOLOGY INC (NASDAQ), BIOMX INC (NYSE American), CEL-SCI CORP (NYSE American), X4 PHARMACEUTICALS INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), LONGEVERON INC (NASDAQ), SYNLOGIC INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), METACRINE INC (NASDAQ), ORGENESIS INC (NASDAQ), IBIO INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), BRAINSTROM CELL THERAPEUTICS (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), OTONOMY INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), VASCULAR BIOGENICS LTD (NASDAQ), ARAVIVE INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), RECRO PHARMA INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), INFLARX N V (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), LUMOS PHARMA INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), CLEVELAND BIOLABS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), LEAF RESOURCES LTD (ASX), AIKIDO PHARMA INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), UNI-BIO GROUP (HKEx), SYNTHETIC BIOLOGICS INC (NYSE American), CHIMERIC THERAPEUTICS LTD (ASX), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), VACCINEX INC (NASDAQ), ADVAXIS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), GENETIC TECHNOLOGIES (ASX), KIROMIC BIOPHARMA INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), BIOCARDIA INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), REGENT PACIFIC (HKEx), PULMATRIX INCORPORATED (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), SOLIGENIX INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), AURIS MEDICAL HOLDING LTD (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), IDERA PHARMACEUTICALS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), CYCLO THERAPEUTICS INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), MEMPHASYS LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), ADITX THERAPEUTICS INC (NASDAQ), HISTOGEN INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), PATRYS LIMITED (ASX), ORAGENICS INC (NYSE American), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), PRECIPIO INC (NASDAQ), ADALTA LTD (ASX), BIOTRON (ASX), PHIO PHARMACEUTICALS CORP (NASDAQ), Suntar Eco-City (SGX), GEOVAX LABS INC (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), REGENEUS LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), RHINOMED LIMITED (ASX), BRIACELL THERAPEUTICS CORP (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), AMPLIA THERAPEUTICS LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), SENESTECH INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), CRYOSITE (ASX), NANOLLOSE LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), HAO WEN HLDGS (HKEx), LIVING CELL TECHNOLOGIES (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.220
-1.66 %
10 Days --0.620
-4.53 %
20 Days --2.400
-15.52 %
Medium Term Return 3 Months --16.070
-55.17 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 11.530 - 36.490 Change From 1 Year Low +1.530 % Change From 1 Year Low (%) +13.27
Change From 1 Year High -23.430 % Change From 1 Year High (%) -64.21
2 Years Range 11.530 - 36.490 Change From 2 Years Low +1.530 % Change From 2 Years Low (%) +13.27
Change From 2 Years High -23.430 % Change From 2 Years High (%) -64.21
5 Years Range 11.530 - 36.490 Change From 5 Years Low +1.530 % Change From 5 Years Low (%) +13.27
Change From 5 Years High -23.430 % Change From 5 Years High (%) -64.21
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

SQZ Biotechnologies Co. is a clinical-stage biotechnology company, which engages in developing cell therapies for patients with cancer, infectious diseases, and other serious conditions. It operates through SQZ Cell Therapy Platform, which uses membrane disruption to deliver material into cells. The company was founded by Robert S. Langer Jr., Klavis F. Jensen, Agustin Lopez Marquez, and Armon Sharei in March 2013 and is headquartered in Watertown, MA.

Historical Price Data

Date Open High Low Close Volume VWAP
13 Apr 2021 13.660 13.950 12.550 13.030 130,061 -
12 Apr 2021 13.870 13.950 13.110 13.550 152,545 -
09 Apr 2021 13.410 13.750 13.050 13.660 75,594 -
08 Apr 2021 13.490 13.760 13.150 13.520 93,337 -
07 Apr 2021 13.050 13.480 12.840 13.280 140,401 -
06 Apr 2021 13.550 13.650 12.920 13.300 118,011 -
05 Apr 2021 14.000 14.000 13.100 13.380 84,843 -
01 Apr 2021 13.570 13.750 13.310 13.660 107,377 -
31 Mar 2021 13.310 14.000 13.100 13.680 98,934 -
30 Mar 2021 12.000 12.900 11.530 12.840 130,005 -
29 Mar 2021 12.360 12.800 11.790 12.070 153,719 -
26 Mar 2021 13.190 13.400 12.200 12.350 91,896 -
25 Mar 2021 12.940 13.310 12.560 13.260 123,883 -
24 Mar 2021 14.110 14.210 12.750 12.930 125,101 -
23 Mar 2021 14.670 14.740 13.710 14.220 108,154 -
22 Mar 2021 15.170 15.800 14.310 14.660 174,566 -
19 Mar 2021 15.000 16.000 14.660 14.920 283,075 -
18 Mar 2021 15.470 15.980 14.790 15.020 123,488 -
17 Mar 2021 15.800 15.800 14.785 15.460 85,310 -
16 Mar 2021 15.570 16.075 15.360 15.620 130,951 -
15 Mar 2021 14.900 15.596 14.650 15.360 106,429 -
12 Mar 2021 14.510 14.910 14.140 14.900 77,930 -
Summary
Current 2 Weeks
(30 Mar 2021 to 13 Apr 2021)
12.000 14.000 11.530 13.030 1,131,108 -
Previous 2 Weeks
(16 Mar 2021 to 29 Mar 2021)
15.570 16.075 11.530 12.070 1,400,143 -
4 Weeks from
(16 Feb 2021 to 15 Mar 2021)
19.000 19.080 11.530 15.360 5,862,813 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.